vs
GEN Restaurant Group, Inc.(GENK)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是GEN Restaurant Group, Inc.的1.5倍($75.5M vs $49.7M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs -9.0%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $-5.6M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs -1.0%)
GEN韩式烤肉是美国的韩式烤肉自助连锁品牌,门店主要集中于美国西部地区,品牌创立于2011年,截至2024年已发展至43家门店,主打任食韩式烤肉产品,在当地拥有较高的知名度。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
GENK vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.5倍
$49.7M
营收增速更快
PBYI
高出36.7%
-9.0%
自由现金流更多
PBYI
多$20.0M
$-5.6M
两年增速更快
PBYI
近两年复合增速
-1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $49.7M | $75.5M |
| 净利润 | $-1.9M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -24.5% | 22.7% |
| 净利率 | -3.8% | — |
| 营收同比 | -9.0% | 27.7% |
| 净利润同比 | -821.4% | — |
| 每股收益(稀释后) | $-0.37 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GENK
PBYI
| Q4 25 | $49.7M | $75.5M | ||
| Q3 25 | $50.4M | $54.5M | ||
| Q2 25 | $55.0M | $52.4M | ||
| Q1 25 | $57.3M | $46.0M | ||
| Q4 24 | $54.7M | $59.1M | ||
| Q3 24 | $49.1M | $80.5M | ||
| Q2 24 | $53.9M | $47.1M | ||
| Q1 24 | $50.8M | $43.8M |
净利润
GENK
PBYI
| Q4 25 | $-1.9M | — | ||
| Q3 25 | $-566.0K | $8.8M | ||
| Q2 25 | $-261.0K | $5.9M | ||
| Q1 25 | $-301.0K | $3.0M | ||
| Q4 24 | $-206.0K | — | ||
| Q3 24 | $25.0K | $20.3M | ||
| Q2 24 | $277.0K | $-4.5M | ||
| Q1 24 | $496.0K | $-4.8M |
毛利率
GENK
PBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率
GENK
PBYI
| Q4 25 | -24.5% | 22.7% | ||
| Q3 25 | -7.4% | 17.6% | ||
| Q2 25 | -3.4% | 12.7% | ||
| Q1 25 | -3.8% | 8.7% | ||
| Q4 24 | -2.4% | 22.6% | ||
| Q3 24 | 0.2% | 27.4% | ||
| Q2 24 | 3.0% | -4.6% | ||
| Q1 24 | 0.2% | -5.3% |
净利率
GENK
PBYI
| Q4 25 | -3.8% | — | ||
| Q3 25 | -1.1% | 16.2% | ||
| Q2 25 | -0.5% | 11.2% | ||
| Q1 25 | -0.5% | 6.5% | ||
| Q4 24 | -0.4% | — | ||
| Q3 24 | 0.1% | 25.2% | ||
| Q2 24 | 0.5% | -9.6% | ||
| Q1 24 | 1.0% | -11.0% |
每股收益(稀释后)
GENK
PBYI
| Q4 25 | $-0.37 | $0.26 | ||
| Q3 25 | $-0.11 | $0.17 | ||
| Q2 25 | $-0.05 | $0.12 | ||
| Q1 25 | $-0.06 | $0.06 | ||
| Q4 24 | $-0.05 | $0.40 | ||
| Q3 24 | $0.01 | $0.41 | ||
| Q2 24 | $0.06 | $-0.09 | ||
| Q1 24 | $0.11 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.8M | $97.5M |
| 总债务越低越好 | $13.6M | $22.7M |
| 股东权益账面价值 | $26.5M | $130.3M |
| 总资产 | $259.9M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.51× | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
GENK
PBYI
| Q4 25 | $2.8M | $97.5M | ||
| Q3 25 | $4.8M | $94.4M | ||
| Q2 25 | $9.6M | $96.0M | ||
| Q1 25 | $15.4M | $93.2M | ||
| Q4 24 | $23.7M | $101.0M | ||
| Q3 24 | $22.1M | $96.7M | ||
| Q2 24 | $29.2M | $96.8M | ||
| Q1 24 | $28.1M | $107.2M |
总债务
GENK
PBYI
| Q4 25 | $13.6M | $22.7M | ||
| Q3 25 | $10.8M | $34.0M | ||
| Q2 25 | $7.8M | $45.3M | ||
| Q1 25 | $6.5M | $56.7M | ||
| Q4 24 | $6.9M | $68.0M | ||
| Q3 24 | $7.2M | $79.3M | ||
| Q2 24 | $7.6M | $90.7M | ||
| Q1 24 | $7.7M | $102.0M |
股东权益
GENK
PBYI
| Q4 25 | $26.5M | $130.3M | ||
| Q3 25 | $38.1M | $115.3M | ||
| Q2 25 | $41.0M | $104.7M | ||
| Q1 25 | $42.8M | $97.1M | ||
| Q4 24 | $44.1M | $92.1M | ||
| Q3 24 | $46.5M | $71.1M | ||
| Q2 24 | $45.9M | $48.5M | ||
| Q1 24 | $40.4M | $51.0M |
总资产
GENK
PBYI
| Q4 25 | $259.9M | $216.3M | ||
| Q3 25 | $245.5M | $202.9M | ||
| Q2 25 | $246.3M | $194.9M | ||
| Q1 25 | $232.4M | $196.2M | ||
| Q4 24 | $240.4M | $213.3M | ||
| Q3 24 | $225.7M | $220.7M | ||
| Q2 24 | $218.8M | $205.0M | ||
| Q1 24 | $214.5M | $214.1M |
负债/权益比
GENK
PBYI
| Q4 25 | 0.51× | 0.17× | ||
| Q3 25 | 0.28× | 0.30× | ||
| Q2 25 | 0.19× | 0.43× | ||
| Q1 25 | 0.15× | 0.58× | ||
| Q4 24 | 0.16× | 0.74× | ||
| Q3 24 | 0.16× | 1.12× | ||
| Q2 24 | 0.17× | 1.87× | ||
| Q1 24 | 0.19× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-426.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-5.6M | $14.4M |
| 自由现金流率自由现金流/营收 | -11.3% | 19.1% |
| 资本支出强度资本支出/营收 | 10.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-24.3M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
GENK
PBYI
| Q4 25 | $-426.0K | $14.4M | ||
| Q3 25 | $-1.6M | $9.7M | ||
| Q2 25 | $3.3M | $14.1M | ||
| Q1 25 | $2.2M | $3.6M | ||
| Q4 24 | $7.3M | $15.6M | ||
| Q3 24 | $1.4M | $11.0M | ||
| Q2 24 | $5.6M | $1.0M | ||
| Q1 24 | $3.5M | $11.2M |
自由现金流
GENK
PBYI
| Q4 25 | $-5.6M | $14.4M | ||
| Q3 25 | $-7.7M | $9.7M | ||
| Q2 25 | $-6.3M | $14.1M | ||
| Q1 25 | $-4.7M | $3.6M | ||
| Q4 24 | $165.0K | $15.6M | ||
| Q3 24 | $-6.8M | $11.0M | ||
| Q2 24 | $1.2M | $1.0M | ||
| Q1 24 | $-586.0K | — |
自由现金流率
GENK
PBYI
| Q4 25 | -11.3% | 19.1% | ||
| Q3 25 | -15.3% | 17.7% | ||
| Q2 25 | -11.5% | 26.8% | ||
| Q1 25 | -8.2% | 7.7% | ||
| Q4 24 | 0.3% | 26.4% | ||
| Q3 24 | -13.9% | 13.7% | ||
| Q2 24 | 2.3% | 2.1% | ||
| Q1 24 | -1.2% | — |
资本支出强度
GENK
PBYI
| Q4 25 | 10.5% | 0.0% | ||
| Q3 25 | 12.0% | 0.0% | ||
| Q2 25 | 17.5% | 0.0% | ||
| Q1 25 | 11.9% | 0.1% | ||
| Q4 24 | 13.1% | 0.0% | ||
| Q3 24 | 16.9% | 0.0% | ||
| Q2 24 | 8.0% | 0.0% | ||
| Q1 24 | 8.1% | 0.0% |
现金转化率
GENK
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 57.96× | 0.54× | ||
| Q2 24 | 20.06× | — | ||
| Q1 24 | 7.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图